DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q1 2023 13F-HR Holdings
Net value change ($000)
-345,338
(-7.1%)
New positions
18
Sold out positions
12
Turnover %
20.2%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CPRX | 62,237 | 56.9% |
| VTRS | 51,624 | 46.4% |
| Deciphera Pharmaceuticals, Inc. | 42,124 | 109.4% |
| Intra-Cellular Therapies, Inc. | 39,746 | NEW |
| ACH | 33,245 | 144.4% |
| LUNG | 26,862 | NEW |
| DCGO | 26,460 | NEW |
| BCRX | 23,060 | NEW |
| CNC | 21,615 | 46.6% |
| VTYX | 20,670 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| SRPT | -165,398 | -100.0% |
| NUVL | -73,767 | -12.4% |
| PHR | -44,214 | -100.0% |
| AMLX | -41,286 | -41.5% |
| IVERIC bio, Inc. | -36,720 | -50.1% |
| ImmunoGen, Inc. | -31,537 | -100.0% |
| ANAB | -22,666 | -63.0% |
| PCVX | -22,508 | -67.1% |
| SPRY | -22,378 | -23.7% |
| DAWN | -20,746 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|